Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months
Orion Biotechnology Publishes White-paper Highlighting the Importance and Challenges in Unlocking “Undruggable” GPCRs
Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable Al-Driven Drug Discovery Against Undrugged GPCR Target